Global /China /Healthcare /Drug Manufacturers - General /603168

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

603168

• SSE: 603168 • Delayed

6.74CNY 0%

0.9930 USD

As of 4 July 2026, Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. has a market cap of $371.49M USD, ranking #17188 globally and #5370 in China. It ranks #1566 in the Healthcare sector, and #564 in the Drug Manufacturers - General industry.

Global Rank

17188

1d: -5

1w: -

1m: -

Country Rank

5370

1d: -6

1w: -

1m: -

Sector Rank

1566

1d: -3

1w: -

1m: -

Industry Rank

564

1d: 0

1w: -

1m: -

Key Stats

Market Cap

$371.49MUSD

2.52B CNY

Enterprise Value

$382.77MUSD

2.6B CNY

Revenue (TTM)

$68.18MUSD

462.78M CNY

EBITDA (TTM)

$4.77MUSD

32.37M CNY

Net Income (TTM)

-$35.17MUSD

-238.72M CNY

EBITDA Margin

Profit Margin

-52%

PS Ratio

5.4

PB Ratio

1.9

EV/EBITDA

67.2

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Hong Li Lin open_in_new

Employees

1,328

Founded

2000

Website

zjspas.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	5.3%	-3.2%	-11%	-17%	-8.8%	3.5%	-30%	-17%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	603168 浙江莎普爱思药业股份有限公司 Class A ISIN: CNE100001TG0 Shares Out.: Shares Outstanding: 372.515M¹ Shares Float: 284.696M² TV: TradingView: SSE: 603168 SA: Stock Analysis: SHA: 603168 YF: Yahoo Finance: 603168.SS GF: Google Finance: SHA: 603168 BA: Barron's: 603168 MS: Morningstar: XSHG: 603168	6.74 CNY	TV: TradingView: SSE: 603168 SA: Stock Analysis: SHA: 603168 YF: Yahoo Finance: 603168.SS GF: Google Finance: SHA: 603168 BA: Barron's: 603168 MS: Morningstar: XSHG: 603168

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 2000 and is based in Pinghu, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.76B 364.89B CNY 14K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.55B 336.36B CNY 13K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.5B 223.48B HKD 8K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.78B 147.32B HKD 5K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.48B 111.89B CNY 4K%	-	China
Akeso, Inc. SHEK: 9926	$16.0B 125.46B HKD 4K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 205K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 147K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 97K%	97.4	United States
Roche Holding AG SIX: RO	$318.9B 256.25B CHF 86K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$287.77B 215.59B GBP 77K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 74K%	15.1	United States

chevron_leftBack